CYCOTIAMINE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C13H16N4O3S
Molecular Weight	308.356
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	1
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC(N(CC1=C(N)N=C(C)N=C1)C=O)=C2CCOC(=O)S2

InChI

InChIKey=LLJDJQYGZBQFIF-DHZHZOJOSA-N

InChI=1S/C13H16N4O3S/c1-8(11-3-4-20-13(19)21-11)17(7-18)6-10-5-15-9(2)16-12(10)14/h5,7H,3-4,6H2,1-2H3,(H2,14,15,16)/b11-8+

HIDE SMILES / InChI

Description
Sources: http://repository.kulib.kyoto-u.ac.jp/dspace/bitstream/2433/119923/1/14_0767.pdf
Curator's Comment: description was created based on several sources, including, http://www.drugfuture.com/mt/thiamine-nitrate.pdf

Cycotiamine is a derivative of tiamine that was developed in Japan and used for the treatment of neurogenic bladder.

Approval Year

Conditions

Condition	Modality	Targets	Highest Phase	Product
Neurogenic bladder 6 Sources: http://www.ncbi.nlm.nih.gov/pubmed/5751425	Palliative		Approved 8429	COMETAMIN Approved Use Unknown

PubMed

Title	Date	PubMed

Patents

Sample Use Guides

In Vivo Use Guide

900 to 3,700 mg given by intravenous administration.

Route of Administration: Intravenous

In Vitro Use Guide

Unknown

Name

Type

Language

CYCOTIAMINE

Official Name

English

N-((4-AMINO-2-METHYL-5-PYRIMIDINYL)METHYL)-N-(1-(2-OXO-1,3-OXATHIAN-4-YLIDENE)ETHYL)FORMAMIDE

Systematic Name

English

CYCOTIAMINE [MART.]

Common Name

English

cycotiamine [INN]

Common Name

English

COMMETAMIN

Brand Name

English

CYCLOCARBOTHIAMINE

Common Name

English

Cycotiamine [WHO-DD]

Common Name

English

CYCOTIAMINE [JAN]

Common Name

English

CYCOTHIAMIN(E) [MI]

Common Name

English

CARBOTHIAMINE

Common Name

English

COMETAMINE

Brand Name

English

N-(1-(2-OXO-1,3-OXATHIAN-4-YLIDENE)ETHYL)-N-((4-AMINO-2-METHYL-5-PYRIMIDINYL)METHYL)FORMAMIDE

Systematic Name

English

CYCOTHIAMIN(E)

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C45812